Human Rotavirus Vaccine Market Analysis from 2022 to 2034 Containing Market Size, Share along with its CAGR, Forecast and Trends

Top Countries — Revenue

USD Million/Billion
Loading…

Access the full forecast model.

Country-level data · Company profiles · Editable dataset · Analyst consultation included.

Human Rotavirus Vaccine Market Analysis — Presence

Geographical Analysis

Click countries to explore
Loading map…

Regional and Country Analysis

Region / Country 2021 (A)2025 (A)2033 (P) CAGR
Globalxxxxxxxxxxxxxxxx
North Americaxxxxxxxxxxxxxxxx
United Statesxxxxxxxxxxxxxxxx
Canadaxxxxxxxxxxxxxxxx
Mexicoxxxxxxxxxxxxxxxx
Europexxxxxxxxxxxxxxxx
United Kingdomxxxxxxxxxxxxxxxx
Francexxxxxxxxxxxxxxxx
Germanyxxxxxxxxxxxxxxxx
Italyxxxxxxxxxxxxxxxx
Russiaxxxxxxxxxxxxxxxx
Spainxxxxxxxxxxxxxxxx
Swedenxxxxxxxxxxxxxxxx
Denmarkxxxxxxxxxxxxxxxx
Switzerlandxxxxxxxxxxxxxxxx
Luxembourgxxxxxxxxxxxxxxxx
Rest of Europexxxxxxxxxxxxxxxx
Asia Pacificxxxxxxxxxxxxxxxx
Chinaxxxxxxxxxxxxxxxx
Japanxxxxxxxxxxxxxxxx
South Koreaxxxxxxxxxxxxxxxx
Indiaxxxxxxxxxxxxxxxx
Australiaxxxxxxxxxxxxxxxx
Singaporexxxxxxxxxxxxxxxx
Taiwanxxxxxxxxxxxxxxxx
South East Asiaxxxxxxxxxxxxxxxx
Rest of APACxxxxxxxxxxxxxxxx
South Americaxxxxxxxxxxxxxxxx
Brazilxxxxxxxxxxxxxxxx
Argentinaxxxxxxxxxxxxxxxx
Colombiaxxxxxxxxxxxxxxxx
Peruxxxxxxxxxxxxxxxx
Chilexxxxxxxxxxxxxxxx
Rest of South Americaxxxxxxxxxxxxxxxx
Middle Eastxxxxxxxxxxxxxxxx
Saudi Arabiaxxxxxxxxxxxxxxxx
Turkeyxxxxxxxxxxxxxxxx
UAExxxxxxxxxxxxxxxx
Egyptxxxxxxxxxxxxxxxx
Qatarxxxxxxxxxxxxxxxx
Rest of Middle Eastxxxxxxxxxxxxxxxx
Africaxxxxxxxxxxxxxxxx
East Africaxxxxxxxxxxxxxxxx
West Africaxxxxxxxxxxxxxxxx
North Africaxxxxxxxxxxxxxxxx
South Africaxxxxxxxxxxxxxxxx

A = Actual · E = Estimated · P = Projected · 🔒 Locked values require full access. Click headers to sort.

Unlock full regional dataset →

Segmentation Analysis


Market size by (Illustrative, 2025)
Share distribution (2025)

Charts are illustrative — exact values, country-level breakdowns, and full forecast in the paid report. Request a Free Sample PDF.

To learn more about market share and segmentation, request the free sample pages.

Competitor Analysis

Major players involved in the market include Bharat Biotech, Serum Institute of India Pvt. Ltd., GlaxoSmithKline plc., Merck & Co., Inc., BIOVIRx Inc., Sanofi, Lanzhou Institute of Biologicals Products Co., Ltd. Among others.

News:

  • Bharat Biotech's rotavirus vaccine received Prequalification from WHO

In August 2021, Bharat Biotech International Limited announced that Rotavac 5D, a variant of its Rotavac vaccine, has received Prequalification from the World Health Organization (WHO). Rotavac vaccine is used to prevent rotavirus which causes severe diarrhea and vomiting and is mostly found in children. This is an important step to further strengthen Bharat Biotech’s position to prevent infections that affect millions in the developing world.

  • FDA Approved Fully Liquid Presentation of GSK’s Rotarix Vaccine to Prevent Gastroenteritis Caused by Rotavirus

In November 2022, GlaxoSmithKline announced that the US Food and Drug Administration (FDA) has approved an oral-dosing applicator presentation liquid formulation of Rotarix which prevents rotavirus gastroenteritis caused by G1 and non-G1 types (G3, G4 and G9) in infants. This new formulation was developed with the vision to make it more convenient for healthcare providers to prepare Rotarix by removing the need to reconstitute the vaccine dose at the point of time.

Click any bar or cell to request the full company profile
Top Companies (In no particular order)2022 (A)2023 (A)2024 (A)2025 (A)
Bharat Biotech••• ••• ••• •••
Serum Institute of India Pvt. Ltd.••• ••• ••• •••
GlaxoSmithKline plc.••• ••• ••• •••
Merck & Co.Inc.••• ••• ••• •••
BIOVIRx Inc.••• ••• ••• •••
Sanofi••• ••• ••• •••
Lanzhou Institute of Biologicals Products Co.Ltd.••• ••• ••• •••
Others••• ••• ••• •••

We Provide Regional Breakdown of this Companies and Company specific to any Country, Region, Product/ service as well. We cover market share analysis for publicly listed companies as well as privately held companies, subject to data availability.

Request company profile for validation →

Report Scope & Analysis

In terms of revenue, Hospitals & clinics was the leading Application with 60.12% share of total Human Rotavirus Vaccine market in 2021

North America was the dominated region with 43.22% of total revenue market share in 2021.

Market Size:

2021: USD 9.37 Bn
2029: USD 20.66 Bn
CAGR (2022-2029): 10.39%

The rotavirus vaccine is an oral vaccine to give protection against type A rotavirus infections that cause vomiting and severe diarrhea in infants and children. The vaccine is around 83% effective at protecting against severe rotavirus infection in the first two years of life. The rotavirus vaccine has significantly reduced the incidence of hospitalization and severe gastroenteritis in childhood. The rotavirus vaccine is administered by putting some drops in the child’s mouth. The rotavirus vaccine has some side effects that are rare and may include fussiness, fever, and diarrhea.

Analyst Conclusion

Sources:

  • Government organizations
  • Magazines
  • Journals
  • News Articles
  • Annual Reports
  • nhs.uk
  • immunizeindia
  • rxlist
  • Others

Supriya Yadav
Supriya Yadav Verified Analyst
Research Analyst · Cognitive Market Research
LinkedIn Profile Book a free Consultation

Frequently Asked Questions

The human rotavirus vaccine market is anticipated to rise at a considerable rate during the forecast period from 2022–2029.
North America has acquired a prominent share in the human rotavirus vaccine market owing to the growing awareness of viral diseases.
The market is segmented into product and application.
The driving factor for the growth of the global human rotavirus vaccine market is increasing incidences of rotavirus infections

★ Reviews

Rate this report

Human Rotavirus Vaccine Market Analysis — Table of Contents

Disclaimer:
  • This is just a redacted sample pages of the actual deliverable report and only for representative purposes
  • Charts/Graphs/Numbers/data are only for Representative purposes and do not depict actual statistics.
  • The table of Contents differs according to the user License selection. Current Displayed TOC is for the Corporate User License Report Edition. TOC Customization options: Add or Remove section/s Or chapter/s from the report.
  • Specific Tables, Graphs, Sections, and Chapters can be ordered at a discounted price.
  • If applicable; On Request Volume Data will also be provided (at an Additional Cost).
License Edition

Product Rotarix, RotaTeq, Rotavac, Rotavin M1, Lanzhou lamb, Others
Application Hospitals & Clinics, Academic And Research, Others
List of Competitors Bharat Biotech, Serum Institute of India Pvt. Ltd., GlaxoSmithKline plc., Merck & Co.Inc., BIOVIRx Inc., Sanofi, Lanzhou Institute of Biologicals Products Co.Ltd., Others

  • 1.1 Top Competitors Analysis

    • (Subject to Data Availability (Private Players))

      1.1.1 Global Human Rotavirus Vaccine Market Analysis by Key Players
    • 1.1.2 Global Human Rotavirus Vaccine Market Volume and Share by Key Players
    • 1.1.3 Top Players Ranking 2024
    • 1.1.4 New Product Launch Analysis
    • 1.1.5 Industry Mergers and Acquisition Analysis
  • 1.2 Company Profile (Data Subject to Availability) Sample Format

    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      1.2.1 Bharat Biotech
      • 1.2.1.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 1.2.1.2 Business Overview
      • 1.2.1.3 Financials (Subject to data availability)
      • 1.2.1.4 R&D Investment (Subject to data availability)
      • 1.2.1.5 Product Types Specification
      • 1.2.1.6 Business Strategy
      • 1.2.1.7 Recent Developments
      • 1.2.1.8 Management Change
      • 1.2.1.9 S.W.O.T Analysis

    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      1.2.2 Serum Institute of India Pvt. Ltd.
      • 1.2.2.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 1.2.2.2 Business Overview
      • 1.2.2.3 Financials (Subject to data availability)
      • 1.2.2.4 R&D Investment (Subject to data availability)
      • 1.2.2.5 Product Types Specification
      • 1.2.2.6 Business Strategy
      • 1.2.2.7 Recent Developments
      • 1.2.2.8 Management Change
      • 1.2.2.9 S.W.O.T Analysis

    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      1.2.3 GlaxoSmithKline plc.
      • 1.2.3.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 1.2.3.2 Business Overview
      • 1.2.3.3 Financials (Subject to data availability)
      • 1.2.3.4 R&D Investment (Subject to data availability)
      • 1.2.3.5 Product Types Specification
      • 1.2.3.6 Business Strategy
      • 1.2.3.7 Recent Developments
      • 1.2.3.8 Management Change
      • 1.2.3.9 S.W.O.T Analysis

    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      1.2.4 Merck & Co.Inc.
      • 1.2.4.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 1.2.4.2 Business Overview
      • 1.2.4.3 Financials (Subject to data availability)
      • 1.2.4.4 R&D Investment (Subject to data availability)
      • 1.2.4.5 Product Types Specification
      • 1.2.4.6 Business Strategy
      • 1.2.4.7 Recent Developments
      • 1.2.4.8 Management Change
      • 1.2.4.9 S.W.O.T Analysis

    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      1.2.5 BIOVIRx Inc.
      • 1.2.5.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 1.2.5.2 Business Overview
      • 1.2.5.3 Financials (Subject to data availability)
      • 1.2.5.4 R&D Investment (Subject to data availability)
      • 1.2.5.5 Product Types Specification
      • 1.2.5.6 Business Strategy
      • 1.2.5.7 Recent Developments
      • 1.2.5.8 Management Change
      • 1.2.5.9 S.W.O.T Analysis

    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      1.2.6 Sanofi
      • 1.2.6.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 1.2.6.2 Business Overview
      • 1.2.6.3 Financials (Subject to data availability)
      • 1.2.6.4 R&D Investment (Subject to data availability)
      • 1.2.6.5 Product Types Specification
      • 1.2.6.6 Business Strategy
      • 1.2.6.7 Recent Developments
      • 1.2.6.8 Management Change
      • 1.2.6.9 S.W.O.T Analysis

    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      1.2.7 Lanzhou Institute of Biologicals Products Co.Ltd.
      • 1.2.7.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 1.2.7.2 Business Overview
      • 1.2.7.3 Financials (Subject to data availability)
      • 1.2.7.4 R&D Investment (Subject to data availability)
      • 1.2.7.5 Product Types Specification
      • 1.2.7.6 Business Strategy
      • 1.2.7.7 Recent Developments
      • 1.2.7.8 Management Change
      • 1.2.7.9 S.W.O.T Analysis

    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      1.2.8 Others
      • 1.2.8.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 1.2.8.2 Business Overview
      • 1.2.8.3 Financials (Subject to data availability)
      • 1.2.8.4 R&D Investment (Subject to data availability)
      • 1.2.8.5 Product Types Specification
      • 1.2.8.6 Business Strategy
      • 1.2.8.7 Recent Developments
      • 1.2.8.8 Management Change
      • 1.2.8.9 S.W.O.T Analysis

  • 2.1 Global Human Rotavirus Vaccine Revenue Market Size, Trend Analysis 2022 - 2034
  • 2.2 Global Human Rotavirus Vaccine Volume Market Sales, Trend Analysis 2022 - 2034

  • Global Market has been segmented on the basis 5 major regions such as North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America.

    2.3 Global Human Rotavirus Vaccine Market Analysis By Regions 2022 - 2034
    • 2.3.1 Global Human Rotavirus Vaccine Revenue Market Size By Region
    • 2.3.2 Global Human Rotavirus Vaccine Volume Market Sales By Region
  • 2.4 Global Human Rotavirus Vaccine Market Size By Product 2022 - 2034
    • 2.4.1 Rotarix Market Size
    • 2.4.2 RotaTeq Market Size
    • 2.4.3 Rotavac Market Size
    • 2.4.4 Rotavin M1 Market Size
    • 2.4.5 Lanzhou lamb Market Size
    • 2.4.6 Others Market Size
  • 2.5 Global Human Rotavirus Vaccine Volume Market Sales By Product 2022 - 2034
    • 2.5.1 Rotarix Sales Volume
    • 2.5.2 RotaTeq Sales Volume
    • 2.5.3 Rotavac Sales Volume
    • 2.5.4 Rotavin M1 Sales Volume
    • 2.5.5 Lanzhou lamb Sales Volume
    • 2.5.6 Others Sales Volume
  • 2.6 Global Human Rotavirus Vaccine Market Size By Application 2022 - 2034
    • 2.6.1 Hospitals & Clinics Market Size
    • 2.6.2 Academic And Research Market Size
    • 2.6.3 Others Market Size
  • 2.7 Global Human Rotavirus Vaccine Volume Market Sales By Application 2022 - 2034
    • 2.7.1 Hospitals & Clinics Sales Volume
    • 2.7.2 Academic And Research Sales Volume
    • 2.7.3 Others Sales Volume
  • 2.8 Global Level Competitor Analysis (Subject to Data Availability (Private Players))

  • You can purchase only the Executive Summary of Global Market (2019 vs 2024 vs 2031)

    2.9 Executive Summary Global Market (2021 vs 2025 vs 2033)
    • 2.9.1 Regional Market Revenue Summary 2021 vs 2025 vs 2033
    • 2.9.2 Regional Volume Market Summary 2021 vs 2025 vs 2033
    • 2.9.3 Global Market Revenue Split By Product
    • 2.9.4 Global Volume Market Split By Product
    • 2.9.5 Global Market Revenue Split By Application
    • 2.9.6 Global Volume Market Split By Application

    • Global Market Dynamics, Trends, Drivers, Restraints, Opportunities, Only Pointers will be deliverable

      2.9.7 Global Market Dynamics, Trends, Drivers, Restraints, Opportunities

  • 3.1 North America Human Rotavirus Vaccine Market Outlook
    • 3.1.1 North America Human Rotavirus Vaccine Market Size 2022 - 2034
    • 3.1.2 North America Human Rotavirus Vaccine Volume Market Sales 2022 - 2034
    • 3.1.3 North America Human Rotavirus Vaccine Market Size By Country 2022 - 2034
    • 3.1.4 North America Human Rotavirus Vaccine Volume Market Sales By Country 2022 - 2034
    • 3.1.5 North America Human Rotavirus Vaccine Market Size by Product 2022 - 2034
      • 3.1.5.1 North America Rotarix Market Size
      • 3.1.5.2 North America RotaTeq Market Size
      • 3.1.5.3 North America Rotavac Market Size
      • 3.1.5.4 North America Rotavin M1 Market Size
      • 3.1.5.5 North America Lanzhou lamb Market Size
      • 3.1.5.6 North America Others Market Size
    • 3.1.6 North America Human Rotavirus Vaccine Volume Market Sales by Product 2022 - 2034
      • 3.1.6.1 North America Rotarix Sales Volume
      • 3.1.6.2 North America RotaTeq Sales Volume
      • 3.1.6.3 North America Rotavac Sales Volume
      • 3.1.6.4 North America Rotavin M1 Sales Volume
      • 3.1.6.5 North America Lanzhou lamb Sales Volume
      • 3.1.6.6 North America Others Sales Volume
    • 3.1.7 North America Human Rotavirus Vaccine Market Size by Application 2022 - 2034
      • 3.1.7.1 North America Hospitals & Clinics Market Size
      • 3.1.7.2 North America Academic And Research Market Size
      • 3.1.7.3 North America Others Market Size
    • 3.1.8 North America Human Rotavirus Vaccine Volume Market Sales by Application 2022 - 2034
      • 3.1.8.1 North America Hospitals & Clinics Sales Volume
      • 3.1.8.2 North America Academic And Research Sales Volume
      • 3.1.8.3 North America Others Sales Volume

  • 4.1 Europe Human Rotavirus Vaccine Market Outlook
    • 4.1.1 Europe Human Rotavirus Vaccine Market Size 2022 - 2034
    • 4.1.2 Europe Human Rotavirus Vaccine Volume Market Sales 2022 - 2034
    • 4.1.3 Europe Human Rotavirus Vaccine Market Size By Country 2022 - 2034
    • 4.1.4 Europe Human Rotavirus Vaccine Volume Market Sales By Country 2022 - 2034
    • 4.1.5 Europe Human Rotavirus Vaccine Market Size by Product 2022 - 2034
      • 4.1.5.1 Europe Rotarix Market Size
      • 4.1.5.2 Europe RotaTeq Market Size
      • 4.1.5.3 Europe Rotavac Market Size
      • 4.1.5.4 Europe Rotavin M1 Market Size
      • 4.1.5.5 Europe Lanzhou lamb Market Size
      • 4.1.5.6 Europe Others Market Size
    • 4.1.6 Europe Human Rotavirus Vaccine Volume Market Sales by Product 2022 - 2034
      • 4.1.6.1 Europe Rotarix Sales Volume
      • 4.1.6.2 Europe RotaTeq Sales Volume
      • 4.1.6.3 Europe Rotavac Sales Volume
      • 4.1.6.4 Europe Rotavin M1 Sales Volume
      • 4.1.6.5 Europe Lanzhou lamb Sales Volume
      • 4.1.6.6 Europe Others Sales Volume
    • 4.1.7 Europe Human Rotavirus Vaccine Market Size by Application 2022 - 2034
      • 4.1.7.1 Europe Hospitals & Clinics Market Size
      • 4.1.7.2 Europe Academic And Research Market Size
      • 4.1.7.3 Europe Others Market Size
    • 4.1.8 Europe Human Rotavirus Vaccine Volume Market Sales by Application 2022 - 2034
      • 4.1.8.1 Europe Hospitals & Clinics Sales Volume
      • 4.1.8.2 Europe Academic And Research Sales Volume
      • 4.1.8.3 Europe Others Sales Volume

  • 5.1 Asia Pacific Human Rotavirus Vaccine Market Outlook
    • 5.1.1 Asia Pacific Human Rotavirus Vaccine Market Size 2022 - 2034
    • 5.1.2 Asia Pacific Human Rotavirus Vaccine Volume Market Sales 2022 - 2034
    • 5.1.3 Asia Pacific Human Rotavirus Vaccine Market Size By Country 2022 - 2034
    • 5.1.4 Asia Pacific Human Rotavirus Vaccine Volume Market Sales By Country 2022 - 2034
    • 5.1.5 Asia Pacific Human Rotavirus Vaccine Market Size by Product 2022 - 2034
      • 5.1.5.1 Asia Pacific Rotarix Market Size
      • 5.1.5.2 Asia Pacific RotaTeq Market Size
      • 5.1.5.3 Asia Pacific Rotavac Market Size
      • 5.1.5.4 Asia Pacific Rotavin M1 Market Size
      • 5.1.5.5 Asia Pacific Lanzhou lamb Market Size
      • 5.1.5.6 Asia Pacific Others Market Size
    • 5.1.6 Asia Pacific Human Rotavirus Vaccine Volume Market Sales by Product 2022 - 2034
      • 5.1.6.1 Asia Pacific Rotarix Sales Volume
      • 5.1.6.2 Asia Pacific RotaTeq Sales Volume
      • 5.1.6.3 Asia Pacific Rotavac Sales Volume
      • 5.1.6.4 Asia Pacific Rotavin M1 Sales Volume
      • 5.1.6.5 Asia Pacific Lanzhou lamb Sales Volume
      • 5.1.6.6 Asia Pacific Others Sales Volume
    • 5.1.7 Asia Pacific Human Rotavirus Vaccine Market Size by Application 2022 - 2034
      • 5.1.7.1 Asia Pacific Hospitals & Clinics Market Size
      • 5.1.7.2 Asia Pacific Academic And Research Market Size
      • 5.1.7.3 Asia Pacific Others Market Size
    • 5.1.8 Asia Pacific Human Rotavirus Vaccine Volume Market Sales by Application 2022 - 2034
      • 5.1.8.1 Asia Pacific Hospitals & Clinics Sales Volume
      • 5.1.8.2 Asia Pacific Academic And Research Sales Volume
      • 5.1.8.3 Asia Pacific Others Sales Volume

  • 6.1 South America Human Rotavirus Vaccine Market Outlook
    • 6.1.1 South America Human Rotavirus Vaccine Market Size 2022 - 2034
    • 6.1.2 South America Human Rotavirus Vaccine Volume Market Sales 2022 - 2034
    • 6.1.3 South America Human Rotavirus Vaccine Market Size By Country 2022 - 2034
    • 6.1.4 South America Human Rotavirus Vaccine Volume Market Sales By Country 2022 - 2034
    • 6.1.5 South America Human Rotavirus Vaccine Market Size by Product 2022 - 2034
      • 6.1.5.1 South America Rotarix Market Size
      • 6.1.5.2 South America RotaTeq Market Size
      • 6.1.5.3 South America Rotavac Market Size
      • 6.1.5.4 South America Rotavin M1 Market Size
      • 6.1.5.5 South America Lanzhou lamb Market Size
      • 6.1.5.6 South America Others Market Size
    • 6.1.6 South America Human Rotavirus Vaccine Volume Market Sales by Product 2022 - 2034
      • 6.1.6.1 South America Rotarix Sales Volume
      • 6.1.6.2 South America RotaTeq Sales Volume
      • 6.1.6.3 South America Rotavac Sales Volume
      • 6.1.6.4 South America Rotavin M1 Sales Volume
      • 6.1.6.5 South America Lanzhou lamb Sales Volume
      • 6.1.6.6 South America Others Sales Volume
    • 6.1.7 South America Human Rotavirus Vaccine Market Size by Application 2022 - 2034
      • 6.1.7.1 South America Hospitals & Clinics Market Size
      • 6.1.7.2 South America Academic And Research Market Size
      • 6.1.7.3 South America Others Market Size
    • 6.1.8 South America Human Rotavirus Vaccine Volume Market Sales by Application 2022 - 2034
      • 6.1.8.1 South America Hospitals & Clinics Sales Volume
      • 6.1.8.2 South America Academic And Research Sales Volume
      • 6.1.8.3 South America Others Sales Volume

  • 7.1 Middle East Human Rotavirus Vaccine Market Outlook
    • 7.1.1 Middle East Human Rotavirus Vaccine Market Size 2022 - 2034
    • 7.1.2 Middle East Human Rotavirus Vaccine Volume Market Sales 2022 - 2034
    • 7.1.3 Middle East Human Rotavirus Vaccine Market Size By Country 2022 - 2034
    • 7.1.4 Middle East Human Rotavirus Vaccine Volume Market Sales By Country 2022 - 2034
    • 7.1.5 Middle East Human Rotavirus Vaccine Market Size by Product 2022 - 2034
      • 7.1.5.1 Middle East Rotarix Market Size
      • 7.1.5.2 Middle East RotaTeq Market Size
      • 7.1.5.3 Middle East Rotavac Market Size
      • 7.1.5.4 Middle East Rotavin M1 Market Size
      • 7.1.5.5 Middle East Lanzhou lamb Market Size
      • 7.1.5.6 Middle East Others Market Size
    • 7.1.6 Middle East Human Rotavirus Vaccine Volume Market Sales by Product 2022 - 2034
      • 7.1.6.1 Middle East Rotarix Sales Volume
      • 7.1.6.2 Middle East RotaTeq Sales Volume
      • 7.1.6.3 Middle East Rotavac Sales Volume
      • 7.1.6.4 Middle East Rotavin M1 Sales Volume
      • 7.1.6.5 Middle East Lanzhou lamb Sales Volume
      • 7.1.6.6 Middle East Others Sales Volume
    • 7.1.7 Middle East Human Rotavirus Vaccine Market Size by Application 2022 - 2034
      • 7.1.7.1 Middle East Hospitals & Clinics Market Size
      • 7.1.7.2 Middle East Academic And Research Market Size
      • 7.1.7.3 Middle East Others Market Size
    • 7.1.8 Middle East Human Rotavirus Vaccine Volume Market Sales by Application 2022 - 2034
      • 7.1.8.1 Middle East Hospitals & Clinics Sales Volume
      • 7.1.8.2 Middle East Academic And Research Sales Volume
      • 7.1.8.3 Middle East Others Sales Volume

  • 8.1 Africa Human Rotavirus Vaccine Market Outlook
    • 8.1.1 Africa Human Rotavirus Vaccine Market Size 2022 - 2034
    • 8.1.2 Africa Human Rotavirus Vaccine Volume Market Sales 2022 - 2034
    • 8.1.3 Africa Human Rotavirus Vaccine Market Size By Country 2022 - 2034
    • 8.1.4 Africa Human Rotavirus Vaccine Volume Market Sales By Country 2022 - 2034
    • 8.1.5 Africa Human Rotavirus Vaccine Market Size by Product 2022 - 2034
      • 8.1.5.1 Africa Rotarix Market Size
      • 8.1.5.2 Africa RotaTeq Market Size
      • 8.1.5.3 Africa Rotavac Market Size
      • 8.1.5.4 Africa Rotavin M1 Market Size
      • 8.1.5.5 Africa Lanzhou lamb Market Size
      • 8.1.5.6 Africa Others Market Size
    • 8.1.6 Africa Human Rotavirus Vaccine Volume Market Sales by Product 2022 - 2034
      • 8.1.6.1 Africa Rotarix Sales Volume
      • 8.1.6.2 Africa RotaTeq Sales Volume
      • 8.1.6.3 Africa Rotavac Sales Volume
      • 8.1.6.4 Africa Rotavin M1 Sales Volume
      • 8.1.6.5 Africa Lanzhou lamb Sales Volume
      • 8.1.6.6 Africa Others Sales Volume
    • 8.1.7 Africa Human Rotavirus Vaccine Market Size by Application 2022 - 2034
      • 8.1.7.1 Africa Hospitals & Clinics Market Size
      • 8.1.7.2 Africa Academic And Research Market Size
      • 8.1.7.3 Africa Others Market Size
    • 8.1.8 Africa Human Rotavirus Vaccine Volume Market Sales by Application 2022 - 2034
      • 8.1.8.1 Africa Hospitals & Clinics Sales Volume
      • 8.1.8.2 Africa Academic And Research Sales Volume
      • 8.1.8.3 Africa Others Sales Volume

  • 9.1 Market Drivers
  • 9.2 Market Restraints
  • 9.3 Market Trends
  • 9.4 Market Opportunity
  • 9.5 Technological Road Map (Subject to Data Availability)
  • 9.6 Product Life Cycle (Subject to Data Availability)
  • 9.7 Customer and Buyer Behavior Analysis
    • 9.7.1 Consumer Demographics and Target Audience Assessment
    • 9.7.2 Digital Engagement, Customer Experience & Relationship Analysis
    • 9.7.3 Customer Buying Behavior & Purchase Decision Analysis
    • 9.7.4 Vendor Selection, Supplier Preferences & Future Demand Trends
    • 9.7.5 Pricing, Affordability & Value Perception Analysis
    • 9.7.6 Customer Segmentation & Demand Pattern Analysis
  • 9.8 Market Attractiveness Analysis
  • 9.9 PESTEL Analysis
    • 9.9.1 Political Factors
    • 9.9.2 Economic Factors
    • 9.9.3 Social Factors
    • 9.9.4 Technological Factors
    • 9.9.5 Legal Factors
    • 9.9.6 Environmental Factors
  • 9.10 Industrial Chain Analysis (Subject to Data Availability)
    • 9.10.1 Industry Chain Analysis
    • 9.10.2 Manufacturing Cost Analysis
    • 9.10.3 Supply Side Analysis
      • 9.10.3.1 Raw Material Analysis
      • 9.10.3.2 Raw Material Procurement Analysis
      • 9.10.3.3 Raw Material Price Trend Analysis
  • 9.11 Porter’s Five Forces Analysis
    • 9.11.1 Bargaining Power of Suppliers
    • 9.11.2 Bargaining Power of Buyers
    • 9.11.3 Threat of New Entrants
    • 9.11.4 Threat of Substitutes
    • 9.11.5 Degree of Competition
  • 9.12 Patent Analysis (Subject to Data Availability)
  • 9.13 ESG Analysis
  • 9.14 Geopolitical Outlook
    • 9.14.1 Global Power Realignment & Strategic Alliances
    • 9.14.2 Geopolitical Risk Landscape & Conflict Hotspots
    • 9.14.3 International Trade Relations & Market Access Environment
    • 9.14.4 Regulatory & Policy Shifts Impacting Cross-Border Operations
    • 9.14.5 Supply Chain Resilience, Localization & Resource Nationalism
    • 9.14.6 Technology Sovereignty & Digital Geopolitics
    • 9.14.7 Strategic Implications for Investment, Growth & Market Entry

  • This chapter isn't just about technology; it’s about certainty. We show you how AI is being used in leading industries so you can apply those same 'High-Speed' and 'High-Accuracy' principles to your own market strategy

    9.15 AI & Market Transformation
    • 9.15.1 Competitive Landscape Disruption & Strategic Shifts
    • 9.15.2 AI-Driven Transformation of Industry Value Chain
    • 9.15.3 Evolution of Business Models & Revenue Streams
    • 9.15.4 AI-Driven Product, Service & Innovation Transformation
    • 9.15.5 Customer Behavior, AI Adoption & Future Market Evolution

  • 10.1 Rotarix
    • 10.1.1 Global Human Rotavirus Vaccine Revenue Market Size and Share by Rotarix 2022 - 2034
    • 10.1.2 Global Human Rotavirus Vaccine Volume Market Sales by Rotarix 2022 - 2034
  • 10.2 RotaTeq
    • 10.2.1 Global Human Rotavirus Vaccine Revenue Market Size and Share by RotaTeq 2022 - 2034
    • 10.2.2 Global Human Rotavirus Vaccine Volume Market Sales by RotaTeq 2022 - 2034
  • 10.3 Rotavac
    • 10.3.1 Global Human Rotavirus Vaccine Revenue Market Size and Share by Rotavac 2022 - 2034
    • 10.3.2 Global Human Rotavirus Vaccine Volume Market Sales by Rotavac 2022 - 2034
  • 10.4 Rotavin M1
    • 10.4.1 Global Human Rotavirus Vaccine Revenue Market Size and Share by Rotavin M1 2022 - 2034
    • 10.4.2 Global Human Rotavirus Vaccine Volume Market Sales by Rotavin M1 2022 - 2034
  • 10.5 Lanzhou lamb
    • 10.5.1 Global Human Rotavirus Vaccine Revenue Market Size and Share by Lanzhou lamb 2022 - 2034
    • 10.5.2 Global Human Rotavirus Vaccine Volume Market Sales by Lanzhou lamb 2022 - 2034
  • 10.6 Others
    • 10.6.1 Global Human Rotavirus Vaccine Revenue Market Size and Share by Others 2022 - 2034
    • 10.6.2 Global Human Rotavirus Vaccine Volume Market Sales by Others 2022 - 2034

  • 11.1 Hospitals & Clinics
    • 11.1.1 Global Human Rotavirus Vaccine Revenue Market Size and Share by Hospitals & Clinics 2022 - 2034
    • 11.1.2 Global Human Rotavirus Vaccine Volume Market Sales by Hospitals & Clinics 2022 - 2034
  • 11.2 Academic And Research
    • 11.2.1 Global Human Rotavirus Vaccine Revenue Market Size and Share by Academic And Research 2022 - 2034
    • 11.2.2 Global Human Rotavirus Vaccine Volume Market Sales by Academic And Research 2022 - 2034
  • 11.3 Others
    • 11.3.1 Global Human Rotavirus Vaccine Revenue Market Size and Share by Others 2022 - 2034
    • 11.3.2 Global Human Rotavirus Vaccine Volume Market Sales by Others 2022 - 2034

  • 12.1 Global Human Rotavirus Vaccine Market Export Data (2022-2025)
  • 12.2 Global Human Rotavirus Vaccine Market Import Data by Region (2022-2025)
  • 12.3 Global Human Rotavirus Vaccine Market Export Data by Region (2022-2025)
  • 12.4 North America Human Rotavirus Vaccine Market Import Data by Country (2019-2023)
  • 12.5 North America Human Rotavirus Vaccine Market Export Data by Country (2019-2023)
  • 12.6 Europe Human Rotavirus Vaccine Market Import Data by Country (2019-2023)
  • 12.7 Europe Human Rotavirus Vaccine Market Export Data by Country (2019-2023)
  • 12.8 Asia Pacific Human Rotavirus Vaccine Market Import Data by Country (2019-2023)
  • 12.9 Asia Pacific Human Rotavirus Vaccine Market Export Data by Country (2019-2023)
  • 12.10 South America Human Rotavirus Vaccine Market Import Data by Country (2019-2023)
  • 12.11 South America Human Rotavirus Vaccine Market Export Data by Country (2019-2023)
  • 12.12 Middle East and Africa Human Rotavirus Vaccine Market Import Data by Country (2019-2023)
  • 12.13 Middle East and Africa Human Rotavirus Vaccine Market Export Data by Country (2019-2023)

  • 14.1 Key Takeaways

  • Here the analyst will summarize the content of entire report and will share his view point on the current industry scenario and how the market is expected to perform in the near future. The points shared by the analyst are based on his/her detailed in-depth understanding of the market during the course of this report study. You will be provided exclusive rights to interact with the concerned analyst for unlimited time pre purchase as well as post purchase of the report.

    14.2 Analyst Point of View
  • 14.3 Assumptions and Acronyms

  • 15.1 Primary Data Collection
    • 15.1.1 Steps for Primary Data Collection
      • 15.1.1.1 Identification of KOL
    • 15.1.2 Backward Integration
    • 15.1.3 Forward Integration
    • 15.1.4 How Primary Research Help Us
    • 15.1.5 Modes of Primary Research
  • 15.2 Secondary Research
    • 15.2.1 How Secondary Research Help Us
    • 15.2.2 Sources of Secondary Research
  • 15.3 Data Validation
    • 15.3.1 Data Triangulation
    • 15.3.2 Top Down & Bottom Up Approach
    • 15.3.3 Cross check KOL Responses with Secondary Data
  • 15.4 Data Representation

Athenaeum AI Dashboard

Research Framework · 70:30 Primary:Secondary

Our Proprietary Methodology

Cognitive Market Research and Consulting "The Full Truth" methodology — a rigorous triangulation process that combines primary research, secondary validation, and expert calibration. Implemented by Supriya Yadav and team for the Human Rotavirus Vaccine Market Analysis Market analysis.

01

Primary Intelligence Gathering

Direct interviews with 50+ industry stakeholders including manufacturers, distributors, end-users, and regulatory bodies across all six regions.

02

Secondary Data Triangulation

Cross-referencing against trade databases, customs records, financial filings, patent databases, and verified industry publications.

03

Expert Validation Protocol

Each data point undergoes validation by minimum two independent domain experts with 15+ years of industry experience.

04

Athenaeum AI Processing

Our proprietary AI platform aggregates, normalizes, and identifies patterns across 10,000+ data points to surface non-obvious insights.

05

Editorial & QA Review

Final review by senior analysts ensures accuracy, coherence, and actionability of all insights and recommendations.

Data Assurance Metrics
Data Points Validated 10,400+
Expert Interviews 54
Countries Covered 39+
Company Profiles 8+
Forecast Accuracy (Historical) 94.2%
Report Pages 250+
Analytical Coverage
Market Sizing Revenue Forecast CAGR Analysis Competitor Benchmarking SWOT Porter's Analysis PESTEL Value Chain ESG Analysis Tariff Impact Patent Mapping Tech Trends

To maintain the integrity of our proprietary methodology and protect our elite expert network, specific source disclosures are reserved for full-access partners. Our research framework is anchored by a 70:30 primary-to-secondary ratio, ensuring your strategy is driven by real-time market intelligence rather than recycled, publicly available, or AI-generated data. Every deliverable includes an exhaustive source directory and grants direct analyst access.

Latest News about Human Rotavirus Vaccine Market

Sources from Pharma & Healthcare Industry

How We Serve You

The Three Pillars of End-to-End Market Research Services

We don't just hand over data. We partner with your team across three integrated service lines — each designed to give you decision-grade intelligence on the Human Rotavirus Vaccine Market Analysis market.

Service 01

Market Survey

B2B B2C

Structured primary research across both B2B and B2C channels. We design and execute custom surveys targeting manufacturers, distributors, procurement heads, and end-consumers in the human rotavirus vaccine market analysis ecosystem — validated by our global panel of 10,000+ industrial respondents.

What's Included
  • Buyer intent & sentiment analysis
  • Purchase cycle mapping
  • Price sensitivity research
  • Channel preference profiling
  • Competitive perception study
Most Requested
Service 02

Customized Market Data & Reports

Custom Ready Report

Choose from our ready-to-access 8th Edition report or commission a fully customized dataset tailored to your exact strategic questions. Cross-splits, custom geographies, proprietary segmentation — we build the intelligence asset your board actually needs.

What's Included
  • Ready syndicate report (250+ pages)
  • Custom data scope & segmentation
  • Excel quantitative models
  • Board-ready PPT with key findings
  • Secure cloud portal access
Service 03

Strategic Consultation

With Survey With Report

Every survey and every report comes with dedicated analyst consultation. Our senior research team walks your leadership through findings, answers strategic questions in real-time, and helps translate data into your next board presentation or investment thesis.

What's Included
  • Dedicated analyst assigned to you
  • Live walkthrough of findings
  • Strategic Q&A sessions
  • Go-to-market recommendations
  • NDA-protected engagement

Customize This Report

Tell us the specific segments, regions, or companies you need — and we will tailor the deliverable to your requirements.